Lebanon vs Oman: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Lebanon
0.1%
in 2024
Oman
0.1%
in 2024
Lebanon rank
112th
Oman rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Lebanon
- Oman
How they compare
Lebanon currently reports 0.1% against 0.1% in Oman, a difference of 0.0%.
Across all 10 years both countries report, Oman has been ahead every year.
Lebanon ranks 112th and Oman ranks 112th of 215 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.1% | Oman |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Lebanon or Oman?
- Lebanon, at 0.1% against 0.1% in Oman as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Lebanon and Oman?
- 0.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Oman?
- 10 years are reported by both, from 2015 to 2024.
- How do Lebanon and Oman rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Lebanon ranks 112th and Oman ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.